Bavunalimab, CAS 2329669-78-3

Product Description: Bavunalimab (Anti-Human CTLA4xLAG3) is a bispecific human anti-CTLA-4/LAG-3 monoclonal antibody. Bavunalimab activates T cells in NSG mice. Bavunalimab can be used for the research of cancer[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Perez-Santos M, et, al. Approaches for development of LAG-3 inhibitors and the promise they hold as anticancer agents. Expert Opin Drug Discov. 2022 Nov 24;1-15.

CAS Number: 2329669-78-3

Molecular Weight: N/A

Research Area: Cancer; Inflammation/Immunology

Solubility: H2O

Target: LAG-3

• SKU: MEXHY-P99354-1
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99354-1
• Green Labware: No
• Package Unit: 1mg
• Quantity Unit: STK